Library
3-Cl-PCP
3-Cl-PCP is roughly equipotent to PCP by weight but has a warmer, more euphoric body high and slightly shorter duration compared to 3-MeO-PCP. Subjective amplitude varies widely between individuals; always start low when switching batches as active doses as little as 2 mg IM have been reported. Caustic on nasal tissue; dilute or use a saline wash after insufflation. High doses (30+ mg oral, 25+ mg nasal) increase risk of mania, violent behavior, seizures and prolonged psychosis. Drug checking recommended as 3-Cl-PCP is sometimes mis-sold as 3-MeO-PCP or ketamine.
Also known as: 3-chloro-pcp
Classification
- Chemical: Arylcyclohexylamine
- Psychoactive: Dissociative
- Tag: Hallucinogen
- Tag: Research-Chemical
Effects
- Physical Euphoria
- Stimulation
- Restless Legs
- Spontaneous Bodily Sensations
- Increased Blood Pressure
- Increased Heart Rate
- Cognitive Euphoria
- Conceptual Thinking
- Anxiety Suppression
- Motor Control Loss
- Time Distortion
- Depersonalization
- Perception Of Bodily Lightness
- Disinhibition
- Increased Music Appreciation
- Tactile Enhancement
- Spatial Disorientation
- Visual Distortion
Routes of Administration
Oral
Dosage
- Threshold: 2-3 mg
- Light: 4-8 mg
- Common: 8-18 mg
- Strong: 18-30 mg
- Heavy: 30 mg
Duration
- Onset: 0.25-1 h
- Comeup: 0.5-1.5 h
- Peak: 1-3 h
- Offset: 2-4 h
- After Effects: 6-24 h
Insufflated
Dosage
- Threshold: 1-2 mg
- Light: 3-6 mg
- Common: 6-14 mg
- Strong: 14-25 mg
- Heavy: 25 mg
Duration
- Onset: 0.08-0.33 h
- Comeup: 0.25-0.5 h
- Peak: 1-3 h
- Offset: 2-4 h
- After Effects: 6-24 h
Intramuscular
Dosage
- Threshold: 1 mg
- Light: 2-4 mg
- Common: 4-10 mg
- Strong: 10-18 mg
- Heavy: 18 mg
Duration
- Onset: 0.02-0.08 h
- Comeup: 0.08-0.25 h
- Peak: 1-3 h
- Offset: 2-4 h
- After Effects: 6-24 h
Smoked
Dosage
- Threshold: 1-2 mg
- Light: 2-5 mg
- Common: 5-10 mg
- Strong: 10-18 mg
- Heavy: 18 mg
Duration
- Onset: 0.02-0.08 h
- Comeup: 0.08-0.25 h
- Peak: 1-3 h
- Offset: 2-4 h
- After Effects: 6-24 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
